Journal
MUSCLE & NERVE
Volume 59, Issue 1, Pages 10-22Publisher
WILEY
DOI: 10.1002/mus.26289
Keywords
antibodies; cytokines; lymphocytes; motor neurons; neuroinflammation
Categories
Funding
- Argenta Award through the Wake Forest School of Medicine
- Hope for Tomorrow Foundation
- Blazeman Foundation for ALS
- Tab Williams Family Endowment
- WFSM Brian White ALS Foundation
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS) is a severely debilitating disease characterized by progressive degeneration of motor neurons. Charcot first described ALS in 1869(1); however, its pathogenesis remains unknown, and effective treatments remain elusive. It is apparent that new paradigms must be investigated to understand the effectors of ALS, including inflammation, immune responses, and the body's response to stress and injury. Herein we discuss the potential role of the immune system in ALS pathogenesis and critically review evidence from patient and animal studies. Although immune system components may indeed play a role in ALS pathogenesis, studies implicating immune cells, antibodies, and cytokines in early disease pathology are limited. We propose more focused studies that examine the role of the immune system together with characterized pathogenesis to determine when, where, and if immune and inflammatory processes are critical to disease progression, and thus worthy targets of intervention. Muscle Nerve 59:10-22, 2019
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available